Invesco Pharmaceuticals ETF
PJP
91 hedge funds and large institutions have $85.3M invested in Invesco Pharmaceuticals ETF in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 17 closing their positions.
0.67% more ownership
Funds ownership: 17.18% → 17.85% (+0.67%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 96 → 91 (-5)
15% less capital invested
Capital invested by funds: $101M → $85.3M (-$15.6M)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
35% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.26M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.76M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.82M |
| 4 |
Jane Street
New York
|
+$1.66M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.26M |
| 2 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$2.21M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.92M |
| 4 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
-$1.89M |
| 5 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$1.82M |
PJP Hedge Fund Activity: Q4 2018 in Review
91 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2018, worth a combined $85.3M — down 15% from $101M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of PJP and 14 opened new positions — a net loss of 3 holders — while 31 trimmed existing stakes and 20 added.
The largest buyer was Morgan Stanley, adding an estimated $4.26M. The largest seller was UBS Group, cutting an estimated $3.26M.
- 91 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2018, down from 96 in Q3 2018.
- Funds reported $85.3M of Invesco Pharmaceuticals ETF stock for Q4 2018, down 15% quarter-over-quarter.
- 14 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2018 and 17 closed out, a net change of -3 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2018 was Morgan Stanley, an estimated $4.26M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2018 was UBS Group, an estimated $3.26M sold.
Based on aggregated 13F filings for Q4 2018.